Requirement for ERK activation in sinomenine-induced apoptosis of macrophages

Immunology Letters

Volumn 98, Issue 1, 2005, Pages 91-96

  He, Xiaobo ^a   Wang, Jianli ^a   Guo, Zhenhong ^b   Liu, Qiuyan ^b   Chen, Taoyong ^b   Wang, Xiaojian ^a   Cao, Xuetao ^a,b  

^a ZHEJIANG UNIVERSITY   (China)

^b SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Bax; ERK; Macrophage; p27; Sinomenine

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1B; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN BAX; PROTEIN BCL 2; SINOMENINE;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 15744402274     PISSN: 01652478     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.imlet.2004.10.027     Document Type: Article

References (37)

1. H. Yamasaki Pharmacology of sinomenine, an anti-rheumatic alkaloid from Sinomenium acutum Acta Med 30 1976 1 20
2. L. Liu, E. Buchner, D. Beitze, C.B. Schmidt-Weber, V. Kaever, F. Emmrich, and R.W. Kinne Amelioration of rat experimental arthritides by treatment with the alkaloid sinomenine Int J Immunopharmacol 18 1996 529 543
3. B. Vieregge, K. Resch, and V. Kaever Synergistic effects of the alkaloid sinomenine in combination with the immunosuppressive drugs tacrolimus and mycophenolic acid Planta Med 65 1999 80 82
4. L. Liu, K. Resch, and V. Kaever Inhibition of lymphocyte proliferation by the anti-arthritic drug sinomenine Int J Immunopharmacol 16 1994 685 691
5. H. Hojo, Y. Kondo, H. Umeda, T. Tahira, and Y. Hashimoto Effect of sinomenine on antibody responses in mice J Immunopharmacol 7 1985 33 42
6. L. Liu, J. Riese, K. Resch, and V. Kaever Impairment of macrophage eicosanoid and nitric oxide production by an alkaloid from Sinomenium acutum Arzneimittelforschung 44 1994 1223 1226
7. D. Candinas, W. Mark, V. Kaever, T. Miyatake, N. Koyamada, P. Hechenleitner, and W.W. Hancock Immunomodulatory effects of the alkaloid sinomenine in the high responder ACI-to-Lewis cardiac allograft model Transplantation 62 1996 1855 1860
8. Y. Kondo, F. Takano, K. Yoshida, and H. Hojo Protection by sinomenine against endotoxin-induced fulminant hepatitis in galactosamine-sensitized mice Biochem Pharmacol 48 1994 1050 1052
9. A.M. Green, and N.D. Steinmetz Monitoring apoptosis in real time Cancer J 8 2002 82 92
10. Y.J. Choi, T.G. Kim, Y.H. Kim, S.H. Lee, Y.K. Kwon, S.I. Suh, J.W. Park, and T.K. Kwon Immunosuppressant PG490 (triptolide) induces apoptosis through the activation of caspase-3 and down-regulation of XIAP in U937 cells Biochem Pharmacol 66 2003 273 280
11. H. An, Y. Yu, M. Zhang, H. Xu, R. Qi, X. Yan, S. Liu, W. Wang, Z. Guo, J. Guo, Z. Qin, and X. Cao Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2 TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 106 2002 38 45
12. T. Chen, J. Guo, M. Yang, C. Han, M. Zhang, W. Chen, Q. Liu, J. Wang, and X. Cao Cyclosporin, a impairs dendritic cell migration by regulating chemokine receptor expression and inhibiting cyclooxygenase-2 expression Blood 103 2004 413 421
13. P.C. Singhal, P. Sharma, A.A. Kapasi, K. Reddy, N. Franki, and N. Gibbons Morphine enhances macrophage apoptosis J Immunol 160 1998 1886 1893
14. Z. Xia, M. Dickens, J. Raingeaud, R.J. Davis, and M.E. Greenberg Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis Science 270 1995 1326 1331
15. C. Li, S. Chi, N. He, X. Zhang, O. Guicherit, R. Wagner, S. Tyring, and J. Xie IFNalpha induces Fas expression and apoptosis in hedgehog pathway activated BCC cells through inhibiting Ras-Erk signaling Oncogene 23 2004 1608 1617
16. S. Gendron, J. Couture, and F. Aoudjit Integrin alpha2beta1 inhibits Fas-mediated apoptosis in T lymphocytes by protein phosphatase 2A-dependent activation of the MAPK/ERK pathway J Biol Chem 278 2003 48633 48643
17. S. Zelivianski, M. Spellman, M. Kellerman, V. Kakitelashvilli, X.W. Zhou, E. Lugo, M.S. Lee, R. Taylor, T.L. Davis, R. Hauke, and M.F. Lin ERK inhibitor PD098059 enhances docetaxel-induced apoptosis of androgen-independent human prostate cancer cells Int J Cancer 107 2003 478 485
18. J.G. Shelton, L.S. Steelman, E.R. White, and J.A. McCubrey Synergy between PI3K/Akt and Raf/MEK/ERK Pathways in IGF-1R mediated cell cycle progression and prevention of apoptosis in hematopoietic cells Cell Cycle 3 2004 372 379
19. X. Wang, J.L. Martindale, and N.J. Holbrook Requirement for ERK activation in cisplatin-induced apoptosis J Biol Chem 275 2000 39435 39443
20. Y.J. Choi, S.Y. Lim, J.H. Woo, Y.H. Kim, Y.K. Kwon, S.I. Suh, S.H. Lee, W.Y. Choi, J.G. Kim, I.S. Lee, J.W. Park, and T.K. Kwon Sodium orthovanadate potentiates EGCG-induced apoptosis that is dependent on the ERK pathway Biochem Biophys Res Commun 305 2003 176 185
21. K. Hiromura, J.W. Pippin, M.L. Fero, J.M. Roberts, and S.J. Shankland Modulation of apoptosis by the cyclin-dependent kinase inhibitor p27(Kip1) J Clin Invest 103 1999 597 604
22. C.J. Sherr, and J.M. Roberts Inhibitors of mammalian G1 cyclin-dependent kinases Genes Dev 9 1995 1149 1163
23. K. Nakayama, N. Ishida, M. Shirane, A. Inomata, T. Inoue, N. Shishido, I. Horii, and D.Y. Loh Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors Cell 85 1996 707 720
24. M. Fero, E. Randall, K. Gurley, J. Roberts, and C. Kemp The murine gene p27Kip1 is haplo-insufficient for tumour suppression. Nature (London) 396 1998 177 180
25. S.L. Chan, and V.C. Yu Proteins of the bcl-2 family in apoptosis signalling: from mechanistic insights to therapeutic opportunities Clin Exp Pharmacol Physiol 31 2004 119 128
26. T. Hennet, G. Bertoni, C. Richter, and E. Peterhans Expression of BCL-2 protein enhances the survival of mouse fibrosarcoid cells in tumor necrosis factor-mediated cytotoxicity Cancer Res 53 1993 1456 1460
27. P. Marchetti, T. Hirsch, N. Zamzami, M. Castedo, D. Decaudin, S. Susin, B. Masse, and G. Kroemer Mitochondrial permeability transition triggers lymphocyte apoptosis J Immunol 157 1996 4830 4836
28. G. Baffy, T. Miyashita, J.R. Williamson, and J.C. Reed Apoptosis induced by withdrawal of interleukin-3 (IL-3) from an IL-3-dependent hematopoietic cell line is associated with repartitioning of intracellular calcium and is blocked by enforced Bcl-2 oncoprotein production J Biol Chem 268 1993 6511 6519
29. 2+ fluxes Proc Natl Acad Sci. USA 91 1994 6569 6573
30. M.J. Boucher, J. Morisset, P.H. Vachon, J.C. Reed, J. Laine, and N. Rivard MEK/ERK signaling pathway regulates the expression of Bcl-2, Bcl-X(L), and Mcl-1 and promotes survival of human pancreatic cancer cells J Cell Biochem 79 2000 355 369
31. -/- mice Am J Physiol Renal Physiol 283 2002 1085 1090
32. J.F. Kurland, D.W. Voehringer, and R.E. Meyn The MEK/ERK pathway acts upstream of NF kappaB1 (p50) homodimer activity and Bcl-2 expression in a murine B-cell lymphoma cell line MEK inhibition restores radiation-induced apoptosis. J Biol Chem 278 2003 32465 32470
33. S.A. Park, H.J. Park, B.I. Lee, Y.H. Ahn, S.U. Kim, and K.S. Choi Bcl-2 blocks cisplatin-induced apoptosis by suppression of ERK-mediated p53 accumulation in B104 cells. Mol Brain Res 93 2001 18 26
34. J.H. Baek, J.E. Jang, C.M. Kang, H.Y. Chung, N.D. Kim, and K.W. Kim Hypoxia-induced VEGF enhances tumor survivability via suppression of serum deprivation-induced apoptosis Oncogene 19 2000 4621 4631
35. M. Kortylewski, P.C. Heinrich, M.E. Kauffmann, M. Bohm, A. MacKiewicz, and I. Behrmann Mitogen-activated protein kinases control p27/Kip1 expression and growth of human melanoma cells. Biochem J 357 2001 297 303
36. D. Das, G. Pintucci, and A Stern MAPK-dependent expression of p21(WAF) and p27(kip1) in PMA-induced differentiation of HL60 cells FEBS Lett 472 2000 50 52
37. N. Bonnefoy-Berard, A. Aouacheria, C. Verschelde, L. Quemeneur, A. Marcais, and J. Marvel Control of proliferation by Bcl-2 family members Biochim Biophys Acta 1644 2004 159 168